See What HealthDay Can Do For You
Contact Us

December 2009 Briefing - HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for December 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Review Discusses Anti-HIV Benefits of Male Circumcision

MONDAY, Dec. 28 (HealthDay News) -- Findings from three randomized trials in Africa lend support to the use of adult male circumcision to reduce the incidence of HIV, according to a review published in the January issue of The Journal of Urology.

Abstract
Full Text

Patients Often Lack Knowledge of Their Own Medications

THURSDAY, Dec. 10 (HealthDay News) -- Patients routinely under-report, or even over-report, their outpatient and inpatient medications, and should be included in hospital medication management to improve safety, according to a study published online Dec. 10 in the Journal of Hospital Medicine.

Abstract
Full Text (subscription or payment may be required)

Lab Monitoring Offers Little Benefit to African HIV Efforts

WEDNESDAY, Dec. 9 (HealthDay News) -- Antiretroviral therapy (ART) in Africa can be successfully carried out without constant laboratory monitoring, allowing limited funds to be reallocated to drugs, according to a study published online Dec. 9 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Comment (subscription or payment may be required)

Children's Sexual Debut Often Precedes Parental Discussion

MONDAY, Dec. 7 (HealthDay News) -- Parents do discuss sexual matters with their children, but topics such as birth control and partner condom refusal are often brought up after the child's sexual debut, according to a study published online Dec. 7 in Pediatrics.

Abstract
Full Text

Tenofovir DF-Emtricitabine Is Effective Initial HIV Therapy

TUESDAY, Dec. 1 (HealthDay News) -- As initial therapy in patients with HIV-1, treatment with abacavir-lamivudine may be less successful than treatment with tenofovir disoproxil fumarate (DF)-emtricitabine, according to a study published online Dec. 1 in the New England Journal of Medicine.

Abstract
Full Text (subscription or payment may be required)

Observing Antiretroviral Therapy Yields Little Benefit

TUESDAY, Dec. 1 (HealthDay News) -- HIV-infected patients on antiretroviral therapy who administer the drugs themselves achieve similar rates of adherence to the drug regimen as those who are directly observed taking their medication, according to a study published online Dec. 1 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Comment (subscription or payment may be required)

Women Researchers Lag Behind Men in Grant Awards

TUESDAY, Dec. 1 (HealthDay News) -- Female physicians with a proven interest in research are less likely to receive prestigious research grants from the National Institutes of Health (NIH) than are male physicians, according to a study in the Dec. 1 issue of the Annals of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing
undefined
undefinedundefined